ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0406

Are the BASDAI & BASFI Capturing the Full Impact of Disease Activity on Quality of Life in Women with Axial Spondyloarthritis?

Sinead Maguire1, Fiona Wilson2, Phil Gallagher3 and Finbar (Barry) O'Shea1, 1St James' Hospital, Dublin, Ireland, 2Trinity College Dublin, Dublin, Ireland, 3St Vincent's University Hospital, Dublin, Ireland

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Patient reported outcomes, spondyloarthritis, Spondyloarthropathies, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Treatment Poster I: AxSpA

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The tools to assess disease activity and quality of life in axial spondyloarthritis (axSpA) were developed in ankylosing spondylitis cohorts biased towards inclusion of males. At present, it remains unclear how these tools capture disease experience in females. The Ankylosing Spondylitis Registry of Ireland (ASRI) is an epidemiological data source on patients with axSpA in Ireland. The aim was to examine and compare sex specific relationships between disease activity (as assessed by BASDAI) and quality of life (as assessed by ASQoL) in patients with axSpA.>

Methods: IBM SPSS version 26 was used to run the analysis of the patient population registered in the ASRI to date. Patients with both BASDAI and ASQoL scores were included. Variables were assessed with a Shapiro-Wilk’s test for normal distribution. Variables were also assessed for presence of a monotonic relationship by visual inspection of a scatterplot of the two variables. Once a monotonic relationship was established, records were split by sex and a Spearman’s rank-order correlation was undertaken to assess strength of correlation of scores within each sex.

Results: Overall, 888 patients were assessed for inclusion. Data on both BASDAI and ASQoL scores were available for analysis on 879 patients. For both outcomes means were significantly higher in females compared to males (BASDAI 4.57 vs 3.83, p< 0.01; ASQoL 7.51 vs 6.12, p< 0.01). There was a statistically significant, strong positive correlation between BASDAI and ASQoL scores in the axSpA patients, rs =0.765, p< 0.01, translating clinically to higher BASDAI scores being associated with worse ASQoL scores. Analysis by sex showed the positive correlation becomes stronger if assessed within each sex for men (figure 1) but weaker for women (Males rs(644) =0.774, p< 0.01 vs Females rs(238)= 0.728, p< 0.01) (figure 2).

Conclusion: This analysis demonstrates that there is a stronger relationship between disease activity and quality of life in men with axSpA than women. This raises the question, are lower levels of increased disease activity resulting greater negative impact on quality of life in women compared to axSpA men? Striving to answer this is critical to improving interpretation of patient outcomes between sexes in axSpA. Furthermore, this highlights the need for development and validation of tools to capture disease activity and patient experience of women with axSpA.

Supporting image 1

Figure 1: Correlation between BASDAI and ASQoL in Males with AxSpA

Supporting image 2

Figure 2: Correlation between BASDAI and ASQoL in Females with AxSpA


Disclosures: S. Maguire, None; F. Wilson, None; P. Gallagher, None; F. O'Shea, AbbVie/Abbott.

To cite this abstract in AMA style:

Maguire S, Wilson F, Gallagher P, O'Shea F. Are the BASDAI & BASFI Capturing the Full Impact of Disease Activity on Quality of Life in Women with Axial Spondyloarthritis? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/are-the-basdai-basfi-capturing-the-full-impact-of-disease-activity-on-quality-of-life-in-women-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-the-basdai-basfi-capturing-the-full-impact-of-disease-activity-on-quality-of-life-in-women-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology